Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony L Cunningham

Showing results (201-210 of 208) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 208 results.
Human Vaccines & Immunotherapeutics|June 20, 2019
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trialsLidia Oostvogels, Thomas C Heineman, Robert W Johnson, et al.
Ebiomedicine|November 29, 2024
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsLok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
Nature Communications|April 13, 2021
Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cellsJake W Rhodes, Rachel A Botting, Kirstie M Bertram, et al.
Nature Communications|June 23, 2019
Identification of HIV transmitting CD11c<sup>+</sup> human epidermal dendritic cellsKirstie M Bertram, Rachel A Botting, Heeva Baharlou, et al.
The New England Journal of Medicine|September 15, 2016
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or OlderAnthony L Cunningham, Himal Lal, Martina Kovac, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2021
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70Céline Boutry, Andrew Hastie, Javier Diez-Domingo, et al.
Ebiomedicine|April 1, 2023
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population levelAnouschka Akerman, Vanessa Milogiannakis, Tyra Jean, et al.
Nature Communications|May 19, 2022
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severityWuji Zhang, Brendon Y Chua, Kevin J Selva, et al.
Pageof 21

Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
Human Vaccines & Immunotherapeutics|June 20, 2019
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trialsLidia Oostvogels, Thomas C Heineman, Robert W Johnson, et al.
Ebiomedicine|November 29, 2024
Bivalent Omicron BA.1 vaccine booster increases memory B cell breadth and neutralising antibodies against emerging SARS-CoV-2 variantsLok Bahadur Shrestha, Katie Tungatt, Anupriya Aggarwal, et al.
Nature Communications|April 13, 2021
Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cellsJake W Rhodes, Rachel A Botting, Kirstie M Bertram, et al.
Nature Communications|June 23, 2019
Identification of HIV transmitting CD11c<sup>+</sup> human epidermal dendritic cellsKirstie M Bertram, Rachel A Botting, Heeva Baharlou, et al.
The New England Journal of Medicine|September 15, 2016
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or OlderAnthony L Cunningham, Himal Lal, Martina Kovac, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 20, 2021
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70Céline Boutry, Andrew Hastie, Javier Diez-Domingo, et al.
Ebiomedicine|April 1, 2023
Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population levelAnouschka Akerman, Vanessa Milogiannakis, Tyra Jean, et al.
Nature Communications|May 19, 2022
SARS-CoV-2 infection results in immune responses in the respiratory tract and peripheral blood that suggest mechanisms of disease severityWuji Zhang, Brendon Y Chua, Kevin J Selva, et al.
Pageof 21